Publicaciones en colaboración con investigadores/as de University of Manchester (267)

2024

  1. Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA

    Annals of Oncology, Vol. 35, Núm. 9, pp. 805-816

  2. Avoiding the use of long-term parenteral support in patients without intestinal failure: A position paper from the European Society of Clinical Nutrition & Metabolism, the European Society of Neurogastroenterology and Motility and the Rome Foundation for Disorders of Gut–Brain Interaction

    Neurogastroenterology and Motility, Vol. 36, Núm. 9

  3. Avoiding the use of long-term parenteral support in patients without intestinal failure: A position paper from the European Society of Clinical Nutrition & Metabolism, the European Society of Neurogastroenterology and Motility and the Rome Foundation for Disorders of Gut–Brain Interaction

    Clinical Nutrition, Vol. 43, Núm. 9, pp. 2279-2282

  4. Corrigendum to “Operational recommendations for the implementation of home parenteral nutrition program of care according to the guidelines of the European society for clinical nutrition and metabolism” [Clin Nutr ESPEN 63 (2024) 668–675, (S2405457724012609), (10.1016/j.clnesp.2024.07.1056)]

    Clinical Nutrition ESPEN

  5. Development and validation of prediction models for fetal growth restriction and birthweight: an individual participant data meta-analysis

    Health technology assessment (Winchester, England), Vol. 28, Núm. 47, pp. 1-119

  6. Distinct potassium channel types in brain capillary pericytes

    Biophysical Journal, Vol. 123, Núm. 14, pp. 2110-2121

  7. Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group

    Leukemia, Vol. 38, Núm. 9, pp. 1985-1991

  8. Operational recommendations for the implementation of home parenteral nutrition program of care according to the guidelines of the European society for clinical nutrition and metabolism

    Clinical Nutrition ESPEN

  9. Patients’ and caregivers’ perspective on challenges and outcomes with tube feeding: Analysis of home enteral nutrition survey data

    Clinical Nutrition ESPEN, Vol. 61, pp. 94-100

  10. Quality-of-care standards in adult type 3 intestinal failure caused by benign disease: A European society of clinical nutrition and metabolism (ESPEN) position paper

    Clinical Nutrition ESPEN, Vol. 63, pp. 696-701

  11. Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson’s disease study

    Brain, Vol. 147, Núm. 8, pp. 2652-2667

  12. Type I interferon regulates interleukin-1beta and IL-18 production and secretion in human macrophages

    Life Science Alliance, Vol. 7, Núm. 6

2023

  1. A Retrospective Chart Review of Treatment Patterns and Overall Survival among a Cohort of Patients with Relapsed/Refractory Mycosis Fungoides in France, Germany, Italy, Spain and the United Kingdom

    Cancers, Vol. 15, Núm. 23

  2. A multi-national survey of experience and attitudes towards managing catheter related blood stream infections for home parenteral nutrition

    Clinical Nutrition ESPEN, Vol. 57, pp. 126-130

  3. A second update on mapping the human genetic architecture of COVID-19

    Nature

  4. Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry

    Genome Medicine, Vol. 15, Núm. 1

  5. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 9, pp. 2803-2811

  6. Drug survival and safety of biosimilars and originator adalimumab in the treatment of psoriasis: a multinational cohort study

    BMJ open, Vol. 13, Núm. 7, pp. e075197

  7. EAACI guidelines on the diagnosis of IgE-mediated food allergy

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 12, pp. 3057-3076

  8. Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results

    Nature Medicine, Vol. 29, Núm. 9, pp. 2259-2267